Catalyst Pharmaceuticals, Inc. (CPRX)
27.48
-0.20
(-0.72%)
USD |
NASDAQ |
Apr 24, 13:26
Catalyst Pharmaceuticals EPS Diluted (Quarterly) : 0.4136 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Indivior Pharmaceuticals, Inc. | 0.816 |
| United Therapeutics Corp. | 7.702 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.70M |
| Revenue (Quarterly) | 152.61M |
| Total Expenses (Quarterly) | 99.92M |
| Enterprise Value | 2.674B |
| Gross Profit Margin (Quarterly) | 76.71% |
| Profit Margin (Quarterly) | 34.53% |
| Earnings Yield | 6.13% |
| Operating Earnings Yield | 7.37% |
| Normalized Earnings Yield | 6.110 |